Good points, Buck, thanks. My biggest takeaway from Dr Jay's words is how they "broke the mold" in the most public and dramatic way yet re: Leronlimab's potential.

This even jumps out more considering how reticent our board and CEO's have been since Nader's departure; stung by 2 years in the penalty box by the FDA, "no communication" has been our business and usual. And when comms have come, they are limited, conservative, and fairly restrained.

So in light of this, when Dr Jay starts showing an NP level of enthusiasm?

I wonder if he's had a look at some very promising but as-yet unreleased results. After the wipeouts we've had by accelerating too fast, I have to believe that Dr Jay can back up, by solid results, everything he's recently said.